Free Trial

Stifel Nicolaus Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble logo with Consumer Staples background

Procter & Gamble (NYSE:PG - Get Free Report) had its price target dropped by analysts at Stifel Nicolaus from $167.00 to $161.00 in a research note issued on Friday,Benzinga reports. The firm presently has a "hold" rating on the stock. Stifel Nicolaus' price target points to a potential downside of 0.22% from the stock's previous close.

Several other brokerages have also recently weighed in on PG. UBS Group decreased their price target on Procter & Gamble from $196.00 to $189.00 and set a "buy" rating for the company in a research note on Thursday. Royal Bank of Canada reiterated a "sector perform" rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a report on Thursday. Wells Fargo & Company reduced their price objective on shares of Procter & Gamble from $190.00 to $176.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Finally, Evercore ISI lifted their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research note on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $179.65.

Get Our Latest Analysis on PG

Procter & Gamble Trading Up 0.5 %

NYSE:PG traded up $0.85 during mid-day trading on Friday, hitting $161.35. 7,218,206 shares of the company's stock were exchanged, compared to its average volume of 6,773,879. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. Procter & Gamble has a fifty-two week low of $146.28 and a fifty-two week high of $180.43. The company has a 50 day simple moving average of $169.32 and a 200-day simple moving average of $169.39. The firm has a market capitalization of $379.98 billion, a P/E ratio of 27.82, a PEG ratio of 3.41 and a beta of 0.45.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble's revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.83 earnings per share. As a group, research analysts expect that Procter & Gamble will post 6.93 earnings per share for the current year.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 47,847 shares of the business's stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares of the company's stock, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Procter & Gamble

Institutional investors have recently modified their holdings of the business. Acorn Creek Capital LLC grew its stake in Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock valued at $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. grew its position in Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock valued at $963,000 after buying an additional 59 shares during the period. Traveka Wealth LLC increased its holdings in Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock worth $616,000 after buying an additional 60 shares during the last quarter. Allen Mooney & Barnes Investment Advisors LLC raised its position in Procter & Gamble by 0.7% in the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company's stock worth $1,507,000 after acquiring an additional 61 shares during the period. Finally, Valued Wealth Advisors LLC boosted its stake in Procter & Gamble by 11.2% in the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company's stock valued at $105,000 after acquiring an additional 61 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines